WASHINGTON — Americans are paying to get a star of the psychedelic medicine movement –- ketamine -– shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble. In this context, recent years have seen an uptick in clinics offering in-person intravenous ketamine treatments for depression, anxiety or chronic pain, though regulations and practices vary across American states. Its CEO Juan Pablo Cappello estimated it has served over 3,000 ketamine patients so far. “We have very, very little evidence for our understanding of how effective ketamine is for depression at scale,” he added. Yet for people like 36-year-old New Yorker Philip Markle, who underwent an at-home treatment with a company called Mindbloom, ketamine is a profoundly useful tool.

Source: Philippine Daily Inquirer February 20, 2022 15:12 UTC